Wu Yiling Biography: Ethnicity, Net Worth, Age, Wife, Awards, Religion, Businesses, Parents
Wu Yiling is a Chinese physician, entrepreneur, pharmaceutical executive and medical researcher best known as the founder of Yiling Pharmaceutical and for developing a modern theoretical and clinical framework for traditional Chinese medicine’s collateral disease theory.
A fifth-generation practitioner from a family of traditional Chinese doctors, he combined decades of clinical practice and research with pharmaceutical entrepreneurship, building Yiling Pharmaceutical into a major Chinese medicine company.
Trending Now!!:
| Wu Yiling | |
|---|---|
|
|
| Wiki Facts & About Data | |
| Name: | Wu Yiling |
| Born: | 24 October 1949 (age 76 years old) |
| Place of Birth: | Gucheng County, Hebei, China |
| Nationality: | Chinese |
| Ethnicity: | Han Chinese |
| Religion: | Chinese traditional beliefs |
| Parents: | Wu Shisheng, Mrs. Wu |
| Relationship: | Married |
| Children: | Wu Xiangjun, Wu Rui |
| Occupation: | Physician, Entrepreneur, Pharmaceutical Executive, Medical Researcher |
| Net Worth: | $2.6 billion |
Early Life and Education
Wu Yiling was born on 24 October 1949 in Wuwumao Village, Gucheng County, Hebei Province, into a family with a long tradition of practicing traditional Chinese medicine.
His father, Wu Shisheng, was a respected local physician and the fifth-generation doctor in the family, while his mother, Mrs. Wu, raised the family alongside him. Information about his siblings has not been reliably established.
After China’s college entrance examinations were restored, Wu entered Hebei Medical University in 1977 to study traditional Chinese medicine and completed the five-year curriculum in two years.
In September 1979, he entered Nanjing University of Chinese Medicine as a postgraduate student specializing in cardiovascular disease and diabetes, completing his master’s training in 1982.
His heritage is Han Chinese, and his spiritual background is rooted in Chinese traditional beliefs.
Career
Wu Yiling began his professional medical career as an internal-medicine physician specializing in cardiovascular diseases after completing his postgraduate studies.
His clinical experience encouraged him to investigate the traditional Chinese medicine concept of collateral disease, and he spent years developing a systematic theory connecting traditional medical principles with modern clinical research.
In June 1992, he left hospital employment and established the Shijiazhuang Development Zone Medical Research Institute, the predecessor of Yiling Pharmaceutical, with the goal of transforming traditional Chinese medicine theories into standardized pharmaceutical products.
Wu subsequently built Yiling Pharmaceutical into a large integrated pharmaceutical enterprise combining research, manufacturing and healthcare. Under his scientific direction, the company developed medicines including Tongxinluo, Shensong Yangxin, Qiliqiangxin and Lianhua Qingwen.
His research produced major advances in cardiovascular, cerebrovascular and respiratory medicine, while his work helped establish collateral disease as a specialized field of traditional Chinese medicine.
He was elected an academician of the Chinese Academy of Engineering in 2009 and has received one National Technological Invention Second Prize, three National Science and Technology Progress Second Prizes, five provincial or ministerial first prizes and the Ho Leung Ho Lee Foundation Science and Technology Award.
He stepped down as Yiling Pharmaceutical’s chairman in February 2023 and became its lifelong honorary chairman, while continuing his academic and research leadership.
Personal Life
Wu Yiling, 76 years old, has kept his marital life private, and his wife’s name has not been publicly disclosed.
He and his wife have two children, Wu Xiangjun and Wu Rui, both of whom have become closely involved in the family pharmaceutical enterprise.
The family’s involvement in Yiling Pharmaceutical extends beyond his children, with several relatives also holding shares or positions connected to the business.
Net Worth
Wu Yiling has an estimated net worth of $2.6 billion. His wealth derives principally from his ownership interest in Yiling Pharmaceutical, the pharmaceutical company he founded in 1992 and developed into a publicly traded healthcare enterprise.
What People Ask
NOTICE!! NOTICE!! NOTICE!!
At TheCityCeleb, we strive to provide accurate and up-to-date biographies and entertainment news, focusing on celebrities. Our editorial team researches information from reputable sources, including interviews, official statements, and verified media.If you spot an error or have additional details, please contact us at editor@thecityceleb.com. We value your feedback and are committed to maintaining trustworthy content.
